Short article about the difference between the COVID-19 antiviral pills made by Merck and Pfizer mentions ISMP’s January 3, 2022, alert that patients with severe renal impairment should not receive the drug, while those with moderate renal impairment should receive a dose reduction.
For the full text, visit Becker’s Hospital Review online.
More News
ECRI’s report warns of potential safety risks with 10 health technologies, including single-use products, medication cabinets, cybersecurity of cloud-based systems, and ventilator disinfection
I knew if I wanted to become a subject matter expert and advance through the ranks of medication safety specialists, I needed to align myself with the organization considered the gold standard for medication safety information.
This article appeared on the Pharmacy Practice News website on December 15, 2022